ABSTRACT:Epitheloid Hemangioendothelioma is a rare tumor, of low prevalence, with a higher incidence in the female sex in a 3: 1 ratio. The clinical behavior is unpredictable, being the lungs and the liver the most affected organs. The clinical manifestations are diverse and present with weight loss, cough, hemoptysis, chest pain, pleural effusion and dyspnea. Typically it manifests in both lungs with the presence of multiple nodules and infiltration of the pleura that are discovered incidentally by images. Biopsy, histology and immunohistochemistry are essential for diagnosis. Different non-standardized treatments have been described in the world literature from surgical resection, systemic chemotherapy, radiotherapy and recently the use of vascular endothelial growth factors, a promising treatment option in unresectable advanced disease. We describe the case of a 46-year-old male patie...

Objective: To identify clinical oncological characteristics and overall survival in patients with seminoma and non-seminoma germ cell testicular tumor. Methods: Retrospective study in patients with seminoma and non-seminoma germ cell testicular tumors, attended at the Central Military Hospital CRL LUIS ARIAS SCHREIBER, from January 2004 to January 2014. Study variables: tumor markers, stage and treatment. Finally, global survival was realized. Results: During the study period from January 2004 to January 2014, a total of 26 patients were registered with histopathological diagnosis of germ cell tumor between seminomas and nonseminomas. Histopathologically, the most frequent type was germ cell tumor was non-seminoma type (69.23%), 33% of its variants were mixed tumor type, followed by pure choriocarcinoma with 28%, pure embryonic carcinoma 17% , 11% yolk sac and 11% pure teratoma...

Lung cancer is one of the tumors that have the ability to metastasize in the brain and have the ability to penetrate the blood-brain barrier, the clinic is varied depending on the affected site, as well as the associated risks of convulsion. Therefore, the choice of treatment is complex, considering the primary, the number of metastases and the affected sites. Radiation therapy has long been the choice of patients who are not candidates for surgery, the presence of mutations have allowed to provide targeted therapies such as tyrosine kinase inhibitors that penetrate the blood-brain barrier and have been key to therapeutic management.   DOI 10.25176/RFMH.v19.n1.1798

ABSTRACT:Epitheloid Hemangioendothelioma is a rare tumor, of low prevalence, with a higher incidence in the female sex in a 3: 1 ratio. The clinical behavior is unpredictable, being the lungs and the liver the most affected organs. The clinical manifestations are diverse and present with weight loss, cough, hemoptysis, chest pain, pleural effusion and dyspnea. Typically it manifests in both lungs with the presence of multiple nodules and infiltration of the pleura that are discovered incidentally by images. Biopsy, histology and immunohistochemistry are essential for diagnosis. Different non-standardized treatments have been described in the world literature from surgical resection, systemic chemotherapy, radiotherapy and recently the use of vascular endothelial growth factors, a promising treatment option in unresectable advanced disease. We describe the case of a 46-year-old male patie...

Objective: To identify clinical oncological characteristics and overall survival in patients with seminoma and non-seminoma germ cell testicular tumor. Methods: Retrospective study in patients with seminoma and non-seminoma germ cell testicular tumors, attended at the Central Military Hospital CRL LUIS ARIAS SCHREIBER, from January 2004 to January 2014. Study variables: tumor markers, stage and treatment. Finally, global survival was realized. Results: During the study period from January 2004 to January 2014, a total of 26 patients were registered with histopathological diagnosis of germ cell tumor between seminomas and nonseminomas. Histopathologically, the most frequent type was germ cell tumor was non-seminoma type (69.23%), 33% of its variants were mixed tumor type, followed by pure choriocarcinoma with 28%, pure embryonic carcinoma 17% , 11% yolk sac and 11% pure teratoma...

Lung cancer is one of the tumors that have the ability to metastasize in the brain and have the ability to penetrate the blood-brain barrier, the clinic is varied depending on the affected site, as well as the associated risks of convulsion. Therefore, the choice of treatment is complex, considering the primary, the number of metastases and the affected sites. Radiation therapy has long been the choice of patients who are not candidates for surgery, the presence of mutations have allowed to provide targeted therapies such as tyrosine kinase inhibitors that penetrate the blood-brain barrier and have been key to therapeutic management.   DOI 10.25176/RFMH.v19.n1.1798